Breeding Capital launches two bloodstock ventures

The firm has launched fundraising for its Breeding Capital II and III ventures, aiming to deliver high medium-term returns to shareholders with a portfolio of broodmares, foals and yearlings. Breeding Capital will selectively build up its portfolio of broodmares, sourced both nationally and internationally, estimated to cost on average around £500,000. Under the Enterprise Investment Scheme, investors are able to obtain: 20% upfront tax relief (£400,000 per annum maximum per investor) Capital gains free of tax Reinvestment relief – gains currently taxable at 40% likely to be taxable...